Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan.
Cardiovasc Interv Ther. 2023 Apr;38(2):177-186. doi: 10.1007/s12928-022-00907-6. Epub 2023 Jan 7.
In patients with ST segment elevation and non-ST elevation myocardial infarction (MI), multivessel (MV) coronary artery disease is found in approximately 50%, leading to worse clinical outcomes. Recent data have suggested that complete revascularization with MV percutaneous coronary intervention is associated with a reduced risk of major adverse cardiovascular events as compared to culprit vessel-only revascularization. However, the optimal timing of MV intervention, appropriate non-culprit lesion assessment, and the best revascularization strategy in specific subsets such as cardiogenic shock remain to be established. This review article summarizes current evidence on revascularization strategies in patients with acute MI and MV disease.
在 ST 段抬高和非 ST 段抬高型心肌梗死(MI)患者中,约有 50%存在多支(MV)冠状动脉疾病,导致更差的临床结局。最近的数据表明,与罪犯血管血运重建相比,MV 经皮冠状动脉介入治疗的完全血运重建与降低主要不良心血管事件风险相关。然而,MV 干预的最佳时机、适当的非罪犯病变评估以及在特定亚组(如心源性休克)中的最佳血运重建策略仍有待确定。本文综述了急性 MI 合并 MV 疾病患者的血运重建策略的现有证据。